NL980042I1 - Plaatselijke formuleringen en transdermale afleversystemen die 1-isobutyl-1H-imidazoc4,5-c!chinolin-4-amine bevatten. - Google Patents

Plaatselijke formuleringen en transdermale afleversystemen die 1-isobutyl-1H-imidazoc4,5-c!chinolin-4-amine bevatten.

Info

Publication number
NL980042I1
NL980042I1 NL980042C NL980042C NL980042I1 NL 980042 I1 NL980042 I1 NL 980042I1 NL 980042 C NL980042 C NL 980042C NL 980042 C NL980042 C NL 980042C NL 980042 I1 NL980042 I1 NL 980042I1
Authority
NL
Netherlands
Prior art keywords
imidazoc4
quinolin
isobutyl
amine
delivery systems
Prior art date
Application number
NL980042C
Other languages
English (en)
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of NL980042I1 publication Critical patent/NL980042I1/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL980042C 1988-12-15 1998-12-14 Plaatselijke formuleringen en transdermale afleversystemen die 1-isobutyl-1H-imidazoc4,5-c!chinolin-4-amine bevatten. NL980042I1 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28493388A 1988-12-15 1988-12-15

Publications (1)

Publication Number Publication Date
NL980042I1 true NL980042I1 (nl) 1999-02-01

Family

ID=23092090

Family Applications (1)

Application Number Title Priority Date Filing Date
NL980042C NL980042I1 (nl) 1988-12-15 1998-12-14 Plaatselijke formuleringen en transdermale afleversystemen die 1-isobutyl-1H-imidazoc4,5-c!chinolin-4-amine bevatten.

Country Status (14)

Country Link
EP (1) EP0376534B1 (nl)
JP (1) JP2915034B2 (nl)
KR (1) KR0150445B1 (nl)
AU (1) AU631585B2 (nl)
CA (1) CA2004597C (nl)
DE (2) DE68911499T2 (nl)
DK (1) DK176121B1 (nl)
ES (1) ES2062043T3 (nl)
HK (1) HK1006275A1 (nl)
IE (1) IE62569B1 (nl)
IL (1) IL92537A (nl)
NL (1) NL980042I1 (nl)
NZ (1) NZ231655A (nl)
ZA (1) ZA899450B (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232740A (en) * 1989-04-20 1992-06-25 Riker Laboratories Inc Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
WO1995004551A1 (fr) * 1993-08-10 1995-02-16 Fujisawa Pharmaceutical Co., Ltd. Preparation absorbable par voie percutanee
DE4434775A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
CZ20012446A3 (cs) * 1999-01-08 2002-01-16 3M Innovative Properties Company Farmaceutický prostředek pro léčbu onemocnění sliznice
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
EP1390383B1 (en) * 2001-05-11 2012-02-29 Isis Pharmaceuticals, Inc. Antisense permeation enhancers
CA2446622C (en) * 2001-05-11 2012-08-14 Elan Corporation, Plc Isostearic acid salts as permeation enhancers
CN1292751C (zh) * 2002-04-23 2007-01-03 四川大学 皮肤局部用咪喹莫特或其衍生物脂质体及其制备方法和用途
JP4891066B2 (ja) * 2003-03-13 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 皮膚の質を改善する方法
US7704977B2 (en) 2006-04-07 2010-04-27 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
ES2393761T3 (es) 2006-07-14 2012-12-27 Stiefel Research Australia Pty Ltd Espuma farmacéutica de ácido graso
AU2007275815A1 (en) * 2006-07-18 2008-01-24 Wirra Ip Pty. Ltd. Immune response modifier formulations
WO2009137078A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
ES2940736B2 (es) 2021-11-09 2023-09-19 Ntd Labs S L U Uso combinado de imiquimod y de un hidrolizado de caseina para el tratamiento de condilomas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
EP0196769B1 (en) * 1985-02-25 1992-07-08 Rutgers, The State University of New Jersey A novel transdermal pharmaceutical absorption dosage unit
CA1288698C (en) * 1985-08-30 1991-09-10 Yie W. Chien Transdermal anti-anginal pharmaceutical dosage

Also Published As

Publication number Publication date
DK613889A (da) 1990-06-16
ES2062043T3 (es) 1994-12-16
CA2004597A1 (en) 1990-06-15
IE893888L (en) 1990-06-15
NZ231655A (en) 1992-06-25
AU4670689A (en) 1990-06-21
IE62569B1 (en) 1995-02-08
EP0376534B1 (en) 1993-12-15
AU631585B2 (en) 1992-12-03
DE19975026I2 (de) 2010-07-08
IL92537A (en) 1994-04-12
DE68911499D1 (de) 1994-01-27
KR900009084A (ko) 1990-07-02
CA2004597C (en) 2000-02-08
DK176121B1 (da) 2006-09-11
DK613889D0 (da) 1989-12-06
KR0150445B1 (ko) 1998-10-15
ZA899450B (en) 1990-09-26
HK1006275A1 (en) 1999-02-19
JPH02282327A (ja) 1990-11-19
EP0376534A1 (en) 1990-07-04
DE68911499T2 (de) 1994-06-30
IL92537A0 (en) 1990-08-31
JP2915034B2 (ja) 1999-07-05

Similar Documents

Publication Publication Date Title
NL980042I1 (nl) Plaatselijke formuleringen en transdermale afleversystemen die 1-isobutyl-1H-imidazoc4,5-c!chinolin-4-amine bevatten.
DK51590A (da) System til topisk afgivelse
MX9203480A (es) Formulaciones medicinales en aereosol.
DE68910833D1 (de) Polylactid-zubereitungen.
DE3685856D1 (de) Kuegelchen enthaltende artikel, sowie druckempfindliches klebeband.
DE3786481D1 (de) Topische antimikrobielle arzneimittel.
DE68911473D1 (de) Arzneimittelformulierungen.
NL193420B (nl) Antibiotische verbindingen, preparaten die deze bevatten en gebruik ervan.
IT9048521A0 (it) Dispositivo di somministrazione.
DE68922011D1 (de) Postgebühren-Buchungssystem.
DE58904831D1 (de) Mehrfachinfusionssystem.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
DE68903192D1 (de) Orale praeparate.
FI894688A0 (fi) Flytande oralt tagbart terapeutiskt system.
DE68907794D1 (de) Positioniermittel.
NO166012C (no) Beskyttelsesanordning.
NO890453L (no) Artropodicide preparater.
DE3576118D1 (de) Pharmazeutische praeparate.
FI890729A0 (fi) Anordning foer montering av delarna i en vinkelremledning.
ATE37850T1 (de) Liefervorrichtung.
NO903569L (no) Oppkallssystem.
NO883609D0 (no) Farmasoeytiske preparater for topisk anvendelse.
IT8721990A0 (it) Composizione ad uso topico avente attivita' tricogena, antiforfora ed antiseborroica.
NO900927D0 (no) Topisk avleveringssystem.
NO901018L (no) Topisk hematopofyrin.